Nycomed's Turkey pharma feeds 60% turnover goal in emerging markets
This article was originally published in Scrip
Executive Summary
Nycomed has further strengthened its position in emerging markets by acquiring the rights to a product portfolio in Turkey previously held by Biomeks ?laç.